Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis
2009
167 citations
Journal Article
Field-Weighted Citation Impact:
8.62
·
University of Cincinnati
Piotr Krzeski
·
Procter & Gamble (United Kingdom)
C Yeh
·
Procter & Gamble (United States)
Christi A. Messer
·
Procter & Gamble (United States)
Stephen B. Hanauer
·
University of Chicago
Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis | Researchclopedia